Eli Lilly and Co.Foundayo SampleFoundayo™ (orforglipron) 0.8mg oral tablets. Oral GLP-1 receptor agonist. 30 film-coated tablets per bottle (starting dose, 30-day supply).
Indications and Usage
INDICATIONS AND USAGE
FOUNDAYO TM is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.
Limitations of Use
Concomitant use with another GLP-1 receptor agonist is not recommended.
More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows
HOW IT WORKSThe easy way to access samples
1
Confirm EligibilitySamples are available for authorized US healthcare providers2
Create Free AccountRequest, track, and manage samples from multiple brands3
Get your SampleSamples shipped directly to your practice doorWant to check your eligibility to order samples?
WHO IS PRESCRIBERPOINTIncreasing patient access to medications they needAt PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.
200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed
WHAT HCPS ARE SAYING
FAQsAll you need to know to order samples
Due to manufacturer restrictions, there are some limitations on the quantities of samples that can be included in each order. We're working on new functionality to let your practice place larger, batch orders.